A Multi-centre, Prospective, Observational Study on Effectiveness and Safety of ZOLADEX® (Goserelin Acetate Implant) 10.8 mg and ZOLADEX® (Goserelin Acetate Implant) 3.6 mg in Chinese Patients With Localized or Locally Advanced Hormonal Treatment -naïve Prostate Cancer

Clinical trial NCT03193060 · COMPLETED

Trial details

NCT number: NCT03193060
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Localized or Locally Advanced Prostate Cancer

Start date: 2017-09-19
Primary completion: 2019-12-27
Enrollment: 308

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.